China Pharma Holdings CPHI
NYSE CPHI
$0.65 -0.02 (-2.99%)
At close: Sep 30, 2026 · 4:00 PM EDT

China Pharma Holdings (CPHI) Non Operating Interest Expenses (2010 - 2026)

Updated

China Pharma Holdings (CPHI) recorded Non Operating Interest Expenses of $26,359 in Q2 2026, down 3.7% from $27,359 a year earlier but up 1.3% from the prior quarter.

Analysis

China Pharma Holdings (CPHI) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends

On a TTM basis, China Pharma Holdings' Non Operating Interest Expenses came in at $66,067 as of Jun 30, 2026, down 4.3% year-over-year; for FY2025, it was $27,272, down 0.3% from FY2024.

  • Annual Non Operating Interest Expenses has declined for four straight years, with a five-year compound annual growth rate of -37.9% (FY2020 to FY2025).
  • Across earlier years, Non Operating Interest Expenses came in at $27,353 in FY2024 (-10.5%), $30,572 in FY2023 (-93.0%), $434,619 in FY2022 (-19.8%) and $542,001 in FY2021 (+84.3%).
  • Quarterly Non Operating Interest Expenses has ranged from -$252,776 in Q4 2023 to $333,441 in Q4 2021 over the past five years.
  • On a year-over-year basis, Non Operating Interest Expenses rose in three of the last seven quarters, with growth averaging 72.6%.
  • Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 308.8% in Q1 2025, against a decline of 95.0% in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $26,031 (Q1 2026), $6,879 (Q4 2025) and $6,798 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 China Pharma Holdings 26.34 Mn 25.22 Mn 83,566.00 26,359.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26,359.00
Mar 31, 2026 26,031.00
Dec 31, 2025 6,879.00
Sep 30, 2025 6,798.00
Jun 30, 2025 27,359.00
Mar 31, 2025 28,028.00
Dec 31, 2024 6,802.00
Sep 30, 2024 6,843.00
Jun 30, 2024 6,852.00
Mar 31, 2024 6,856.00
Dec 31, 2023 -252,776.00
Sep 30, 2023 66,240.00
Jun 30, 2023 137,663.00
Mar 31, 2023 79,445.00
Dec 31, 2022 96,175.00
Sep 30, 2022 103,976.00
Jun 30, 2022 110,041.00
Mar 31, 2022 124,427.00
Dec 31, 2021 333,441.00
Sep 30, 2021 64,903.00
API Access

China Pharma Holdings Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CPHI&period=max&api_key=YOUR_API_KEY